Bassler Bonnie L Insider Trades

Insider Trading History

Track insider trading activity for Bassler Bonnie L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $4.34M 78,492 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$254k 4,545 shares
$55.87
$55.34
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $4.09M 73,947 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 815 shares
$45.98
$55.34
Cidara Therapeutics
Cidara Therapeutics CDTX
Director
Holding Value $0 0 shares
Last Trade
Jan 07, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.83M 35,390 shares
$221.38
$221.38
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.98M 3,203 shares
Last Trade
Jan 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.22M 1,500 shares
$812.27
$618.03
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.77M 2,861 shares
Last Trade
Jan 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.22M 1,500 shares
$812.27
$618.03
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.05M 1,703 shares
Last Trade
Jan 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.2M 1,500 shares
$800.00
$618.03
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.21M 1,962 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.52M 2,117 shares
$716.18
$618.03
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $4.05M 73,132 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 967 shares
$38.74
$55.34
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $467k 756 shares
Last Trade
Nov 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$560k 760 shares
$737.00
$618.03
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $957k 1,548 shares
Last Trade
Nov 20, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$570k 760 shares
$750.00
$618.03
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.43M 2,308 shares
Last Trade
Nov 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$560k 760 shares
$737.00
$618.03
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $3.99M 72,165 shares
Last Trade
Sep 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 1,047 shares
$35.79
$55.34
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $3.94M 71,118 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 1,064 shares
$35.24
$55.34
Cidara Therapeutics
Cidara Therapeutics CDTX
Director
Holding Value $2.46M 11,100 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$237k 11,100 shares
$21.31
$221.38
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $3.88M 70,054 shares
Last Trade
May 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 7,614 shares
$32.82
$55.34
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $3.46M 62,440 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 1,141 shares
$32.87
$55.34
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.21M 1,958 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 1,958 shares
$719.37
$618.03
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $3.39M 61,299 shares
Last Trade
Dec 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 1,503 shares
$24.94
$55.34
Cidara Therapeutics
Cidara Therapeutics CDTX
Director
Holding Value $3.54M 16,000 shares
Last Trade
Dec 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$365k 16,000 shares
$22.81
$221.38
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $3.31M 59,796 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 1,342 shares
$27.92
$55.34

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up